SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H. Toumi, D. Benaitreau, S. Pallu, M. Mazor, R. Hambli, M. Ominsky, E. Lespessailles, Effects of anti-sclerostin antibody and running on bone remodeling and strength, Bone Reports, 2015, 2, 52

    CrossRef

  2. 2
    Zachary J. Pritchard, Rachel L. Cary, Chang Yang, Deborah V. Novack, Michael J. Voor, Uma Sankar, Inhibition of CaMKK2 reverses age-associated decline in bone mass, Bone, 2015, 75, 120

    CrossRef

  3. 3
    Hao FU, Hui-chan He, Zhao-dong Han, Yue-ping Wan, Hong-wei Luo, Ya-qiang Huang, Chao Cai, Yu-xiang Liang, Qi-shan Dai, Fu-neng Jiang, Wei-de Zhong, MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer, Tumor Biology, 2015, 36, 3, 1983

    CrossRef

  4. 4
    Y Wu, M Yang, J Fan, Y Peng, L Deng, Y Ding, R Yang, J Zhou, D Miao, Q Fu, Deficiency of osteoblastic Arl6ip5 impaired osteoblast differentiation and enhanced osteoclastogenesis via disturbance of ER calcium homeostasis and induction of ER stress-mediated apoptosis, Cell Death and Disease, 2014, 5, 10, e1464

    CrossRef